Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results.
Clin Cancer Res
; 27(10): 2712-2722, 2021 05 15.
Article
in En
| MEDLINE
| ID: mdl-33753457
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidines
/
Bridged-Ring Compounds
/
Tacrolimus
/
Hematopoietic Stem Cell Transplantation
/
Janus Kinase Inhibitors
/
Graft vs Host Disease
/
Immunosuppressive Agents
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2021
Type:
Article